Mortality of Cancer Surgery During SARS CoV2 Pandemic

February 15, 2022 updated by: Manoj Pandey, Banaras Hindu University

Preoperative Screening for COVID-19 and Strict COVID Cancer Protocol Helps to Reduce Postoperative Infection, Mortality and Morbidity in Cancer Patients Undergoing Surgery. A Comparative Study

The impact of cancer surgery during covid epidemic is not clear. The published reports show contradictory findings that extend from no change in mortality to increased mortality, further no data on exposure and outcome of health care worker is available. This study is designed to address the above questions

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This is a retrospective study from the prospectively collected data that is extracted from the electronic database of Department of Surgical Oncology, IMS, BHU The data is inform of two cohorts one extending from April 2019-April 2020 and other from May 2020 to May 2021 i.e. pre covid and during covid pandemic

Study Type

Observational

Enrollment (Actual)

1576

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • UP
      • Varanasi, UP, India, 221005
        • Banaras Hindu University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 99 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All cases of cancer operated between April 2019 to May 2021

Description

Inclusion Criteria:

  • All patients operated during the study period

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Pre covid
Cases operated one year prior to the date of declaration of corona pandemic in India
Surgery for cancer as per the stage of the disease and protocol
post covid
cases operated from the date of declaration of corona pandemic to one year after
Surgery for cancer as per the stage of the disease and protocol

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
30 day mortality
Time Frame: 30 days
post operative deaths within one year
30 days
number of participants developing major or minor complications
Time Frame: 30 days
Surgical complications classified as per Clavien Dindo classification
30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
number of health care worker with SARS CoV2 infection
Time Frame: 1 year
Covid infection in health care workers
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 29, 2021

Primary Completion (Actual)

December 31, 2021

Study Completion (Actual)

January 15, 2022

Study Registration Dates

First Submitted

February 12, 2022

First Submitted That Met QC Criteria

February 12, 2022

First Posted (Actual)

February 15, 2022

Study Record Updates

Last Update Posted (Actual)

March 3, 2022

Last Update Submitted That Met QC Criteria

February 15, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

IPD will be shared on reasonable request as per Indian law

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Surgery

3
Subscribe